← Back to work
Works cited by this work
73 works
Work: Discovery of novel (E)-1-methyl-9-(3-methylbenzylidene)-6,7,8,9-tetrahydropyrazolo[3,4-d]pyrido[1,2-a]pyrimidin-4(1H)-one as DDR2 kinase inhibitor: Synthesis, molecular docking, and anticancer properties
Design, synthesis, in vitro evaluation of a new pyrrolo[1,2‐<i>a</i>]thiazolo[5,4‐<i>d</i>]pyrimidinone derivatives as cholinesterase inhibitors against Alzheimer's disease
Yan Zeng, Lifei Nie, Liu Liu +6
ArticleCholinesterase and Neurodegenerative DiseasesJournal of Heterocyclic Chemistry202217 citationsABIDesign, synthesis, and toward a side-ring optimization of tricyclic thieno[2,3-<i>d</i>]pyrimidin-4(3<i>H</i>)-ones and their effect on melanin synthesis in murine B16 cells
Li Fei Nie, Khurshed Bozorov, Guozheng Huang +3
ArticleQuinazolinone synthesis and applicationsPhosphorus, sulfur, and silicon and the related elements201814 citationsABISynthesis and Biological Activities of Dihydrooxazolo[5,4-<i>d</i>]-pyrrolo[1,2-<i>a</i>]pyrimidinones
Yan Zeng, Lifei Nie, Chao Niu +4
Article20229 citationsABISynthesis and Antitumor Activity of Novel Linear Tricyclic Compounds Derived from Purine
Haji Akber Aisa, Jiangyu Zhao, Hongmei Guo +2
Article20228 citationsABINew advances in synthesis and clinical aspects of pyrazolo[3,4-d]pyrimidine scaffolds
Khaled R.A. Abdellatif, Rania B. Bakr
Review article20183 citationsABIAnti-inflammatory meroterpenoids from the mangrove endophytic fungus Talaromyces amestolkiae YX1
Senhua Chen, Meng Ding, Weiyang Liu +5
Article20172 citationsABIVascular-disrupting agents in oncology
Monica Mita, Liza Sargsyan, Alain C. Mita +1
Review article20132 citationsABI